Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of 5-ALA for Fluorescence-Guided Resection of Malignant Glioma
DRKS00004966Phase 2Completed
- Sponsor
- medac GmbH
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in malignant glioma and brain neoplasm, sponsored by medac GmbH. Started May 2013; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant gliomabrain neoplasm
Beyond the preview
Go deeper on DRKS00004966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004966.